Navellier & Associates’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-25,916
| Closed | -$2.07M | – | 311 |
|
|
2022
Q2 | $2.07M | Sell |
25,916
-699
| -3% | -$55.8K | 0.44% | 81 |
|
|
2022
Q1 | $2.8M | Sell |
26,615
-10,391
| -28% | -$1.09M | 0.48% | 77 |
|
|
2021
Q4 | $3.99M | Buy |
37,006
+749
| +2% | +$80.7K | 0.58% | 62 |
|
|
2021
Q3 | $3.97M | Buy |
36,257
+988
| +3% | +$108K | 0.6% | 58 |
|
|
2021
Q2 | $3.3M | Buy |
35,269
+892
| +3% | +$83.5K | 0.5% | 71 |
|
|
2021
Q1 | $3.16M | Sell |
34,377
-437
| -1% | -$40.2K | 0.57% | 62 |
|
|
2020
Q4 | $2.55M | Buy |
34,814
+4,954
| +17% | +$362K | 0.46% | 76 |
|
|
2020
Q3 | $2.32M | Buy |
+29,860
| New | +$2.32M | 0.51% | 70 |
|
|
2015
Q4 | – | Sell |
-23,050
| Closed | -$457K | – | 328 |
|
|
2015
Q3 | $457K | Buy |
23,050
+10,550
| +84% | +$209K | 0.05% | 171 |
|
|
2015
Q2 | $434K | Buy |
12,500
+500
| +4% | +$17.4K | 0.04% | 227 |
|
|
2015
Q1 | $312K | Hold |
12,000
| – | – | 0.03% | 275 |
|
|
2014
Q4 | $155K | Buy |
+12,000
| New | +$155K | 0.01% | 318 |
|